Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer

M. Los; J.M.L. Roodhart; E.E. Voest

Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer

Translated title of the contribution: Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer
Original language	Undefined/Unknown
Pages (from-to)	443-450
Number of pages	8
Journal	Oncologist
Volume	12
Publication status	Published - 2007

Cite this

@article{433040bdb9ac4f3883e3a2f07544a859,

title = "Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer",

author = "M. Los and J.M.L. Roodhart and E.E. Voest",

year = "2007",

language = "Undefined/Unknown",

volume = "12",

pages = "443--450",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

}